Diploma PLC (DPLM.L) – What Are Brokerages Thinking About This Stock?

Diploma PLC (LON:DPLM) has been assigned an average rating of “Moderate Buy” from the eight analysts that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is GBX 7,400.

DPLM has been the topic of several research reports. JPMorgan Chase & Co. lifted their price target on shares of Diploma from GBX 5,760 to GBX 8,250 and gave the company an “overweight” rating in a report on Monday, August 24th. Royal Bank Of Canada reissued an “outperform” rating and issued a GBX 7,400 price objective on shares of Diploma in a research note on Tuesday, September 8th. Finally, Berenberg Bank restated a “buy” rating and issued a GBX 9,000 target price on shares of Diploma in a research report on Monday, July 20th.

Insider Activity

In related news, insider Katie Bickerstaffe  purchased 246 shares of the stock in a transaction dated Wednesday, September 23rd. The stock was bought at an average cost of GBX 7,696 per share, for a total transaction of £18,932.16. Company insiders own 1.14% of the company’s stock.

Diploma Stock Down 3.0%

Shares of LON DPLM opened at GBX 7,569.10 on Tuesday. The company has a current ratio of 2.06, a quick ratio of 0.80 and a debt-to-equity ratio of 47.65. The company has a market cap of £10.15 billion, a price-to-earnings ratio of 53.76, a PEG ratio of 2.82 and a beta of 0.92. Diploma has a 12 month low of GBX 4,970 and a 12 month high of GBX 7,980. The stock has a 50-day moving average price of GBX 7,450.78 and a two-hundred day moving average price of GBX 7,154.43.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.